Matt Cavender, MD, MPH, FACC, associate professor of medicine in the division of cardiology, recently published a paper in Diabetes, Obesity and Metabolism with medicine resident Colin P. O’Leary, MD, analyzing new opportunities to utilize real world data.
“Emerging opportunities to harness real world data: An introduction to data sources, concepts, and applications” recognizes randomized controlled trials (RCTs) are the gold standard for comparative effectiveness research, but they are unable to provide the answers to all pertinent clinical and research questions. O’Leary and Cavender assert “real world evidence (RWE), that is, clinical evidence obtained outside RCTs and often through routine clinical practice, offers the potential to conduct observational studies that accelerate advances in care, improve outcomes for patients, and provide important insights that can answer important questions.”
Read the article here.